🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this phase 2 study is to assess the efficacy and safety for ...
Status
Not Yet Recruiting
Location
University of Washington
Start Date
2023-11-15
Trial ID
NCT05794659
The REDUC trial's objective is to address one of the core issues with the t...
Status
Completed
Location
Aarhus University Hospital, Skejby Sygehus
Start Date
2014-03
Trial ID
NCT02092116
Treatments Being Tested
This phase I trial studies the side effects and best dose of multiantigen d...
Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-06
Trial ID
NCT02157051
Treatments Being Tested
Current management of HIV infection includes anti-retroviral therapy (ART)....
Status
Completed
Location
UCLA CARE Center
Start Date
2008-08
Trial ID
NCT00659789
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Cleveland Clinic Cancer Center
Start Date
1998-10
Trial ID
NCT00003490
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability and optim...
Status
Completed
Location
Korea University Anam Hospital
Start Date
2021-06-09
Trial ID
NCT04864418
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of an adju...
Status
Terminated
Location
Ironwood Cancer and Research Centers
Start Date
2022-02-28
Trial ID
NCT05163223
Treatments Being Tested
During the course of HIV infection the number of CD4 cells decreases, resul...
Status
Completed
Location
University Medical Center Hamburg-Eppendorf
Start Date
2012-09
Trial ID
NCT01704781
Treatments Being Tested
The purpose of this early proof-of-concept study to evaluate the safety and...
Status
Active Not Recruiting
Location
Kaohsiung Medical University Chung-Ho Memorial Hospital
Start Date
2023-07-04
Trial ID
NCT05771584
To define the best doses of sargramostim ( granulocyte-macrophage colony-st...
Status
Completed
Location
Mem Sloan - Kettering Cancer Ctr
Start Date
TBD
Trial ID
NCT00000694
Treatments Being Tested